Sponsored Events | ACNM 66th Annual Meeting & Exhibition

Sponsored Events

An Update on LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg
Product Theater sponsored by

Sunday, May 23, 12:00 PM – 1:00 PM ET

Speaker:
Dr. Ashlesha Patel, MD, MPH.

Update and Advancements in the Treatment of Vulvovaginal Candidiasis
Symposium sponsored by

Sunday, May 23, 4:00 PM – 5:00 PM ET

Vulvovaginal Candidiasis (VVC) affects 75% of women at least once in their lifetime. It is a disease that affects women’s daily life, including psychological distress, intimate relationships and lost productivity. In this session, we will provide an update on the epidemiology, diagnostic approaches, current treatment options and new therapeutics in development for nurse-midwives that treat women with VVC.

Speaker:
Oluwatosin (Tosin) Goje, MD, MSCR, FACOG is an Assistant Professor of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Staff in the Obstetrics, Gynecology and Women’s Health Institute at the Cleveland Clinic. She leads the Gynecologic Infectious diseases and Vulvar and Vaginal Disorders Centers in the Institute of Obstetrics, Gynecology and Women’s Health Institute.

Dr. Goje, an obstetrician gynecologist, is also a reproductive infectious diseases specialist and specializes in the evaluation, diagnostic testing and management of obstetric and gynecologic infectious diseases. She also directs the Vulvo-Vaginal Health Clinic. The clinic specializes in infectious and non-infectious disorders of the vulva and vagina. She has published and presented locally and nationally on infectious diseases in women.

She earned a Bachelor of Medicine, Bachelor of Surgery (MBBS) at Ahmadu Bello University in Nigeria. Completed an internship in Internal Medicine at New York Medical College-Metropolitan Hospital, New York, New York. Completed her residency training in Obstetrics and Gynecology at University of Medicine and Dentistry of New Jersey-New Jersey Medical School in Newark, New Jersey. She completed a three year fellowship in Reproductive Infectious Diseases at the Medical University of South Carolina in Charleston, South Carolina, and holds a Master of Science in Clinical Research (MSCR) from the Medical University of South Carolina.

Combining Traditional Screening and the Latest Advancements in Testing to Support Comprehensive Patient Care Throughout Pregnancy
Product Theater sponsored by

Monday, May 24, 1:00 PM – 2:00 PM ET

Since maternal serum screening (MSS) for fetal conditions was initiated in the mid-1970’s, the analysis has evolved, adding conditions and new analytes across both the first and second trimester. In today’s MSS screening methodology, a combination of analytes and ultrasound measurements modifies risk for open neural tube defects and common aneuploidies such as Down syndrome and trisomy 18. MSS has most recently moved into risk assessment for adverse obstetrical outcomes such as preeclampsia.

In 2011, a new approach to aneuploidy screening analyzing cell-free DNA (cfDNA) became available. This new method has gained acceptance by patients and providers due to the higher positive predictive value (PPV) compared to maternal serum screening, as well as its ability to screen for additional fetal conditions including trisomy 13, sex chromosome aneuploidies, and some microdeletion syndromes.

Labcorp has been at the forefront of genetic screening and diagnostics for over 30 years. In this session, we will discuss the evolution of aneuploidy screening from MSS to cfDNA, and the potential to assess risk for preeclampsia using biochemistry and other markers. We will also review additional testing available within one laboratory to support comprehensive patient care, from preconception to the fourth trimester.

Speakers:
Kimberly Fanelli, MS, CGC, Sydney Webb Strickland, PhD, DABCC
Renee Spagnolo, Director, Women’s Health & IVF
Joanna Dorgan, Sr. Product Manager, Women’s Health & Genetics

Use of Telehealth for Contraceptive Counseling
Product Theater sponsored by

Monday, May 24, 2:00 PM – 3:00 PM ET

This program presents information on how to utilize telehealth for counseling on contraceptive options including long acting reversible contraceptives (LARCs), using patient scenarios. The program also reviews how offices can prepare for an efficient visit, when appropriate patients return for their in-person appointment.

Speaker:
Jenna Benyounes, DNP, CNM, WHNP-BC, NCMP

Caring for Women Who Arrive in Threatened Preterm Labor
Symposium sponsored by

Monday, May 24, 2:00 PM – 3:00 PM ET

The goal of this session is to ensure clinicians feel confident caring for women who arrive in threatened preterm labor. Naomi Carlisle, RM, BSc, MRes will use case studies from her own practice and share clinical evidence to highlight how different tools and tests can be used to inform your clinical decision making. Participants will leave this session with a broader understanding of preterm birth, preterm labor triage options available, and appropriate care pathways – enabling them to feel confident when caring for women who arrive in threatened preterm labor.

Speaker:
Naomi Carlisle, RM, BSc, MRes is a clinical academic midwife from London, England, specializing in preterm birth. Her previous roles include working clinically as both a hospital and community midwife, and as a Senior Research Midwife in preterm birth. She currently is undertaking a fully funded National Institute for Health Research Clinical Doctoral Research Fellowship, alongside working clinically on a busy London labor ward. Her PhD study (the IMPART study) is looking at implementation of the Preterm Birth Surveillance Pathway across England. Her work has been recommended nationally by NHS England and the British Association of Perinatal Medicine. You can follow her on twitter @naomihcarlisle and read more of her work here.

Expanding Options in Non-Hormonal Contraception – The Vaginal pH Modulator
Symposium sponsored by

Monday, May 24, 3:00 PM – 4:00 PM ET

Evofem invites you to join us for Expanding Options in Non-hormonal Contraception: The Vaginal pH Modulator. This one-hour session will feature a presentation by Bassem Maximos, MD, MPH, League City, TX, followed by a question and answer session.

Speaker:
Bassem Maximos, MD, MPH, Maximos OB/GYN, League City Texas

Update on Prenatal Genetic Screening: What Midwives Need to Know to Improve Outcomes for Babies
Symposium Sponsored by Natera

Tuesday, May 25, 11:00 AM – 12:00 PM ET

Speaker:
Vivienne Souter, MD, OB/GYN/Clinical Geneticist
Medical Director Women’s Health, Natera